人类免疫缺陷病毒感染个体接种甲型流感病毒疫苗后中和抗体及血凝抑制抗体反应的比较。
Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals.
作者信息
Benne C A, Kroon F P, Harmsen M, Tavares L, Kraaijeveld C A, De Jong J C
机构信息
Eijkman-Winkler Laboratory of Medical Microbiology, University Hospital Utrecht, The Netherlands.
出版信息
Clin Diagn Lab Immunol. 1998 Jan;5(1):114-7. doi: 10.1128/CDLI.5.1.114-117.1998.
Abstract
A neutralization enzyme immunoassay (N-EIA) was used to determine the neutralizing serum antibody titers to influenza A/Taiwan/1/86 (H1N1) and Beijing/353/89 (H3N2) viruses after vaccination of 51 human immunodeficiency virus (HIV) type 1-infected individuals and 10 healthy noninfected controls against influenza virus infection. Overall, the N-EIA titers correlated well with the hemagglutination-inhibition (HAI) titers that were observed in the same samples in a previous study (F. P. Kroon, J. T. van Dissel, J. C. de Jong, and R. van Furth, AIDS 8:469-476,1994). The N-EIA appeared to be more sensitive than the HAI test. Significantly more fourfold or higher rises in N-EIA titer and higher mean N-EIA titers occurred in HIV-infected individuals with > or =200 CD4+ cells per microl than in those with <200 CD4+ cells per microl.
摘要
采用中和酶免疫测定法（N-EIA），检测了51例1型人类免疫缺陷病毒（HIV）感染者和10名健康未感染者接种流感病毒疫苗后，针对甲型流感病毒/台湾/1/86（H1N1）和北京/353/89（H3N2）的血清中和抗体滴度。总体而言，N-EIA滴度与先前研究中在相同样本中观察到的血凝抑制（HAI）滴度密切相关（F.P. Kroon、J.T. van Dissel、J.C. de Jong和R. van Furth，《艾滋病》8:469-476，1994）。N-EIA似乎比HAI试验更敏感。每微升CD4+细胞≥200的HIV感染者中，N-EIA滴度有四倍或更高升高以及平均N-EIA滴度更高的情况，显著多于每微升CD4+细胞＜200的感染者。
相似文献
1
Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals.
Clin Diagn Lab Immunol. 1998 Jan;5(1):114-7. doi: 10.1128/CDLI.5.1.114-117.1998.
2
Neutralization enzyme immunoassay for influenza virus.
J Clin Microbiol. 1994 Apr;32(4):987-90. doi: 10.1128/jcm.32.4.987-990.1994.
3
The impact of vaccination on the breadth and magnitude of the antibody response to influenza A viruses in HIV-infected individuals.
AIDS. 2015 Sep 10;29(14):1803-10. doi: 10.1097/QAD.0000000000000772.
4
Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
Mem Inst Oswaldo Cruz. 2007 Jun;102(4):501-8. doi: 10.1590/s0074-02762007005000055.
5
Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults.
Vaccine. 2023 Jul 31;41(34):4978-4985. doi: 10.1016/j.vaccine.2023.05.055. Epub 2023 Jun 30.
6
Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses.
mSphere. 2021 Mar 10;6(2):e00052-21. doi: 10.1128/mSphere.00052-21.
7
Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.
Vaccine. 2016 Apr 7;34(16):1945-55. doi: 10.1016/j.vaccine.2015.12.038. Epub 2015 Dec 22.
8
Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.
Vaccine. 2014 Feb 3;32(6):657-63. doi: 10.1016/j.vaccine.2013.12.008. Epub 2013 Dec 13.
9
Measuring antibody responses to a live attenuated influenza vaccine in children.
Pediatr Infect Dis J. 2004 Sep;23(9):852-6. doi: 10.1097/01.inf.0000137566.87691.3b.
10
Sensitivity and specificity of enzyme immunoassay for serodiagnosis of influenza A virus infections.
J Infect Dis. 1980 May;141(5):644-51. doi: 10.1093/infdis/141.5.644.
引用本文的文献
1
Chimeric H5 influenza virus-like particle vaccine elicits broader cross-clade antibody responses in chickens than in ducks.
Front Vet Sci. 2023 Jun 15;10:1158233. doi: 10.3389/fvets.2023.1158233. eCollection 2023.
2
Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells.
J Biomed Sci. 2020 Apr 2;27(1):47. doi: 10.1186/s12929-020-00645-y.
3
A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains.
NPJ Vaccines. 2019 Jul 19;4:31. doi: 10.1038/s41541-019-0126-4. eCollection 2019.
4
Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
J Virol. 2018 Sep 26;92(20). doi: 10.1128/JVI.01100-18. Print 2018 Oct 15.
5
Gene signatures associated with adaptive humoral immunity following seasonal influenza A/H1N1 vaccination.
Genes Immun. 2016 Dec;17(7):371-379. doi: 10.1038/gene.2016.34. Epub 2016 Aug 18.
6
Immunogenicity and Clinical Efficacy of Influenza Vaccination in Pregnancy.
Front Immunol. 2015 Jun 4;6:289. doi: 10.3389/fimmu.2015.00289. eCollection 2015.
7
Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine.
PLoS One. 2015 Apr 13;10(4):e0122431. doi: 10.1371/journal.pone.0122431. eCollection 2015.
8
Pregnancy Does Not Attenuate the Antibody or Plasmablast Response to Inactivated Influenza Vaccine.
J Infect Dis. 2015 Sep 15;212(6):861-70. doi: 10.1093/infdis/jiv138. Epub 2015 Mar 4.
9
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective.
PLoS One. 2011;6(12):e29249. doi: 10.1371/journal.pone.0029249. Epub 2011 Dec 22.
10
Fine epitope mapping of monoclonal antibodies against hemagglutinin of a highly pathogenic H5N1 influenza virus using yeast surface display.
Biochem Biophys Res Commun. 2011 Jun 3;409(2):253-9. doi: 10.1016/j.bbrc.2011.04.139. Epub 2011 May 5.
本文引用的文献
1
Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients.
AIDS. 1997 Jul;11(8):1013-21. doi: 10.1097/00002030-199708000-00010.
2
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep. 1997 Apr 25;46(RR-9):1-25.
3
Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals.
Clin Exp Immunol. 1996 May;104(2):203-7. doi: 10.1046/j.1365-2249.1996.25732.x.
4
Response to influenza immunisation in asymptomatic HIV infected men.
Genitourin Med. 1995 Dec;71(6):355-7. doi: 10.1136/sti.71.6.355.
5
Human immunodeficiency virus and acquired immunodeficiency syndrome: an update.
Adv Intern Med. 1994;39:305-55.
6
Neutralization enzyme immunoassay for influenza virus.
J Clin Microbiol. 1994 Apr;32(4):987-90. doi: 10.1128/jcm.32.4.987-990.1994.
7
Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes.
AIDS. 1994 Apr;8(4):469-76. doi: 10.1097/00002030-199404000-00008.
8
Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load.
AIDS. 1994 Oct;8(10):1503-4. doi: 10.1097/00002030-199410000-00022.
9
10
Activation of virus replication after vaccination of HIV-1-infected individuals.
J Exp Med. 1995 Dec 1;182(6):1727-37. doi: 10.1084/jem.182.6.1727.
Zotero 插件